Signaling/NN
events/NNS
induced/VBN
by/IN
lipopolysaccharide-activated/JJ
toll-like/JJ
receptor/NN
2/CD
./.

Human/JJ
Toll-like/JJ
receptor/NN
2/CD
(/(
TLR2/NN
)/)
is/VBZ
a/DT
signaling/NN
receptor/NN
that/WDT
responds/VBZ
to/TO
LPS/NN
and/CC
activates/VBZ
NF-kappaB/NN
./.
=====
Here/RB
,/,
we/PRP
investigate/VBP
further/RBR
the/DT
events/NNS
triggered/VBN
by/IN
TLR2/NN
in/IN
response/NN
to/TO
LPS/NN
./.
=====
We/PRP
show/VBP
that/IN
TLR2/NN
associates/NNS
with/IN
the/DT
high-affinity/JJ
LPS/NN
binding/NN
protein/NN
membrane/NN
CD14/NN
to/TO
serve/VB
as/IN
an/DT
LPS/NN
receptor/NN
complex/NN
,/,
and/CC
that/IN
LPS/NN
treatment/NN
enhances/VBZ
the/DT
oligomerization/NN
of/IN
TLR2/NN
./.
=====
Concomitant/JJ
with/IN
receptor/NN
oligomerization/NN
,/,
the/DT
IL-1R-associated/JJ
kinase/NN
(/(
IRAK/NN
)/)
is/VBZ
recruited/VBN
to/TO
the/DT
TLR2/NN
complex/NN
./.
=====
Intracellular/JJ
deletion/NN
variants/NNS
of/IN
TLR2/NN
lacking/VBG
C-terminal/JJ
13/CD
or/CC
141/CD
aa/NN
fail/VBP
to/TO
recruit/VB
IRAK/NN
,/,
which/WDT
is/VBZ
consistent/JJ
with/IN
the/DT
inability/NN
of/IN
these/DT
mutants/NNS
to/TO
transmit/VB
LPS/NN
cellular/JJ
signaling/NN
./.
=====
Moreover/RB
,/,
both/DT
deletion/NN
mutants/NNS
could/MD
still/RB
form/VB
complexes/NNS
with/IN
wild-type/JJ
TLR2/NN
and/CC
act/VB
in/IN
a/DT
dominant-negative/JJ
(/(
DN/JJ
)/)
fashion/NN
to/TO
block/VB
TLR2-mediated/JJ
signal/NN
transduction/NN
./.
=====
DN/JJ
constructs/NNS
of/IN
myeloid/JJ
differentiation/NN
protein/NN
,/,
IRAK/NN
,/,
TNF/NN
receptor-associated/JJ
factor/NN
6/CD
,/,
and/CC
NF-kappaB-inducing/JJ
kinase/NN
,/,
when/WRB
coexpressed/VBN
with/IN
TLR2/NN
,/,
abrogate/VBP
TLR2-mediated/JJ
NF-kappaB/NN
activation/NN
./.
=====
These/DT
results/NNS
reveal/VBP
a/DT
conserved/VBN
signaling/NN
pathway/NN
for/IN
TLR2/NN
and/CC
IL-1Rs/NNS
and/CC
suggest/VBP
a/DT
molecular/JJ
mechanism/NN
for/IN
the/DT
inhibition/NN
of/IN
TLR2/NN
by/IN
DN/JJ
variants/NNS
./.